FR15C0084I1 - - Google Patents
Info
- Publication number
- FR15C0084I1 FR15C0084I1 FR15C0084C FR15C0084I1 FR 15C0084 I1 FR15C0084 I1 FR 15C0084I1 FR 15C0084 C FR15C0084 C FR 15C0084C FR 15C0084 I1 FR15C0084 I1 FR 15C0084I1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0413510.9A GB0413510D0 (en) | 2004-06-16 | 2004-06-16 | Vaccine |
| US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
| PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR15C0084I1 true FR15C0084I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2016-01-08 |
| FR15C0084I2 FR15C0084I2 (fr) | 2016-10-28 |
Family
ID=35160037
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR15C0084C Active FR15C0084I2 (fr) | 2004-06-16 | 2015-12-04 | Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 |
| FR15C0082C Active FR15C0082I2 (fr) | 2004-06-16 | 2015-12-04 | Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR15C0082C Active FR15C0082I2 (fr) | 2004-06-16 | 2015-12-04 | Vaccin contre les virus hpv16 et hpv18 et au moins un autre type de hpv selectionne parmi hpv 31, 45 ou 52 |
Country Status (18)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG159529A1 (en) * | 2005-04-26 | 2010-03-30 | Glaxosmithkline Biolog Sa | Vaccine |
| WO2010012780A1 (en) * | 2008-07-31 | 2010-02-04 | Glaxosmithkline Biologicals S.A. | Vaccine against hpv |
| PL2444103T3 (pl) * | 2009-06-19 | 2018-05-30 | Eyegene Inc. | Szczepionka przeciwko rakowi szyjki macicy |
| KR20130142104A (ko) * | 2010-07-15 | 2013-12-27 | 브리티쉬 콜롬비아 캔써 에이전시 브랜치 | 인간 파필로마바이러스 e7 항원 조성물 및 이의 용도 |
| KR20150076244A (ko) | 2012-10-30 | 2015-07-06 | 레드박스 게엠베하 | 인간 시토메갈로바이러스 감염에 대한 재조합 입자 기재 백신 |
| MY195018A (en) * | 2014-10-24 | 2023-01-03 | Hpvvax Llc | Cancer and skin lesion treatment |
| CN107188966B (zh) | 2016-03-15 | 2020-03-31 | 中国医学科学院基础医学研究所 | 一种乳头瘤病毒嵌合蛋白及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9921147D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| GB0110431D0 (en) * | 2001-04-27 | 2001-06-20 | Glaxosmithkline Biolog Sa | Novel compounds |
| GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
| CA2510457C (en) * | 2002-12-20 | 2011-12-06 | Glaxosmithkline Biologicals S.A. | Hpv-16 and -18 l1 vlp vaccine |
-
2005
- 2005-06-14 KR KR1020077001065A patent/KR20070029254A/ko not_active Ceased
- 2005-06-14 CA CA2566620A patent/CA2566620C/en not_active Expired - Lifetime
- 2005-06-14 MX MXPA06014515A patent/MXPA06014515A/es active IP Right Grant
- 2005-06-14 AR ARP050102434A patent/AR049354A1/es not_active Application Discontinuation
- 2005-06-14 WO PCT/EP2005/006461 patent/WO2005123125A1/en active Application Filing
- 2005-06-14 SG SG200904200-3A patent/SG153837A1/en unknown
- 2005-06-14 BR BRPI0512042A patent/BRPI0512042B8/pt not_active IP Right Cessation
- 2005-06-14 JP JP2007515878A patent/JP2008502633A/ja active Pending
- 2005-06-14 PE PE2005000677A patent/PE20060434A1/es not_active Application Discontinuation
- 2005-06-14 RU RU2006143804/10A patent/RU2420313C2/ru active
- 2005-06-14 PL PL05757953T patent/PL1758609T3/pl unknown
- 2005-06-14 AU AU2005253723A patent/AU2005253723B2/en active Active
- 2005-06-14 EP EP05757953A patent/EP1758609B1/en not_active Expired - Lifetime
-
2006
- 2006-11-09 IL IL179138A patent/IL179138A0/en unknown
- 2006-12-28 MA MA29576A patent/MA28692B1/fr unknown
-
2007
- 2007-01-11 NO NO20070195A patent/NO20070195L/no not_active Application Discontinuation
-
2015
- 2015-12-04 FR FR15C0084C patent/FR15C0084I2/fr active Active
- 2015-12-04 FR FR15C0082C patent/FR15C0082I2/fr active Active
- 2015-12-08 LU LU92899C patent/LU92899I2/xx unknown
- 2015-12-08 LU LU92900C patent/LU92900I2/xx unknown
- 2015-12-08 LU LU92898C patent/LU92898I2/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR15C0082I2 (fr) | 2016-10-28 |
| EP1758609B1 (en) | 2012-10-03 |
| FR15C0084I2 (fr) | 2016-10-28 |
| RU2420313C2 (ru) | 2011-06-10 |
| BRPI0512042A (pt) | 2008-02-06 |
| BRPI0512042B8 (pt) | 2021-05-25 |
| EP1758609A1 (en) | 2007-03-07 |
| RU2006143804A (ru) | 2008-08-20 |
| PL1758609T3 (pl) | 2013-02-28 |
| PE20060434A1 (es) | 2006-06-08 |
| FR15C0082I1 (fr) | 2016-01-08 |
| MXPA06014515A (es) | 2007-03-23 |
| LU92899I2 (fr) | 2016-03-08 |
| CA2566620A1 (en) | 2005-12-29 |
| IL179138A0 (en) | 2007-03-08 |
| LU92900I2 (fr) | 2016-03-08 |
| SG153837A1 (en) | 2009-07-29 |
| AU2005253723B2 (en) | 2011-01-20 |
| WO2005123125A1 (en) | 2005-12-29 |
| LU92898I2 (fr) | 2016-03-08 |
| NO20070195L (no) | 2007-01-15 |
| AU2005253723A1 (en) | 2005-12-29 |
| BRPI0512042B1 (pt) | 2019-01-22 |
| MA28692B1 (fr) | 2007-06-01 |
| JP2008502633A (ja) | 2008-01-31 |
| CA2566620C (en) | 2014-03-11 |
| AR049354A1 (es) | 2006-07-19 |
| KR20070029254A (ko) | 2007-03-13 |